Symaptics
British company developing pharmaceutical pricing simulation software.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Symaptics is a British company that develops pharmaceutical pricing simulation software. Its platform, SyMAP, is an AI-powered platform for global drug pricing, including International Reference Pricing (IRP) and US Most Favored Nation (MFN) modeling.
History
Symaptics is a British company developing pharmaceutical pricing simulation software. Its platform SyMAP is an AI-powered platform for global drug pricing, including International Reference Pricing (IRP) and US Most Favored Nation (MFN) modeling.
Products and positioning
SyMAP Global Pricing
End-to-end pricing strategy integrating domestic and international pricing analysis.
SyMAP MFN
Models Most Favored Nation pricing across four US programs: GENEROUS, GLOBE, GUARD, and voluntary agreements.
SyMAP IRP
Simulates International Reference Pricing with configurable country rules and a custom formula builder.
Sources5 sources
- 1MFN & IRP Pharmaceutical Pricing Software | Symapticssymaptics.com
- 2SyMAP — AI Software for IRP & MFN Pricing | Symapticssymaptics.com
- 3Pharmaceutical Pricing Analysis & IRP Consulting | Symapticssymaptics.com
- 4International Reference Pricing (IRP) Simulation Softwaresymaptics.com
- 5Symapticswikidata.org
Cite this profile: Cite the canonical profile. /brand-wiki/symaptics · Editorial policy · How profiles are compiled